The Role of MRI Before Breast Conservation

Seminars in Breast Disease

Volumn 10, Issue 4, 2007, Pages 137-144

  Heywang Kobrunner S H ^a   Mohrling D ^a   Nahrig J ^b  

^a Radiologie Haidhausen and Reference Center for Mammography Munich   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

breast cancer; magnetic resonance imaging; preoperative; staging

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 38049055263     PISSN: 10924450     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sembd.2007.10.006     Document Type: Article

References (73)

1. Veronesi U., Cascinelli N., Mariani L., et al. Twenty year follow-up of a randomized study comparing breast conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
2. Fisher B., Wickerham D.L., Deutsch M., et al. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol 8 (1992) 153-160
3. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 3478 (2002) 1233-1241
4. Van Dongen J.A., Voogd A.C., Fentimans I.S., et al. Long-term result of a randomized trial comparing breast-conserving therapy with mastectomy. European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
5. Poggi M.M., Danforth D.N., Sciuto L.C., et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98 (2005) 697-702
6. Blichert-Toft M., Rose C., Anderson J., et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr 11 (1992) 19-25
7. Arriagada R., Lee M.G., Orchard F., et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institute Gustave-Roussy Breast Cancer Group. J Clin Oncol 14 (1996) 1558-1564
8. Ghossein N.A., Alpert S., Barba J., et al. Breast cancer. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively. Arch Surg 127 (1992) 411-415
9. Silverstein M.J. Ductal carcinoma in situ of the breast: a surgeon's disease. Ann Surg Oncol 6 (1999) 802-810
10. Heywang S.H., Hahn D., Schmidt H., et al. MR imaging of the breast using Gd-DTPA. J Comp Assist Tomogr 10 (1986) 199-204
11. Boetes C., Mus R.D., Holland R., et al. Breast tumors: Comparative accuracy of MR imaging relative to mammography and ultrasound for demonstrating extent. Radiology 197 (1995) 743-747
12. Harms S.E., Flaming D.P., Hesley K.L., et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187 (1993) 493
13. Oellinger H., Heins S., Sander B., et al. Gd-DTPA enhanced MRI of the breast: the most sensitive method for detecting multicentric carcinomas in the female breast. Eur Radiol 3 (1993) 223-226
14. Orel S.G., Schnall M.D., Powell C.M., et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196 (1995) 115-122
15. ACR practice guideline for the performance of magnetic resonance imaging (MRI) of the breast. ACR Practice Guideline (2004). http://www.acr.com Available at: http://www.acr.com. (Res. 11) Effective 10.01.2004:341-346
16. AG-Mammdiagnostik der DRG: (Recommendations for MR Mammography.) Empfehlungen zur MR-Mammographie. (Mitteilungen der DRG). RoeFo 177 (2005) 474-475
17. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 292 (2004) 2735-2742
18. Heywang-Köbrunner S.H., Bick U., Bradley Jr. W.G., et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 11 (2001) 531-546
19. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
20. Boné B., Pentek Z., Perbeck L., et al. Diagnostic accuracy of mammography and contrast-enhanced MR-imaging in 238 histologically verified breast lesions. Acta Radiol 38 (1997) 489-496
21. Bedrosian I., Mick R., Orel S.G., et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98 (2003) 468-473
22. Drew P.J., Chatterjee S., Turnbull L.W., et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol 6 (1999) 599-603
23. Esserman L., Hylton N., Yassa L., et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17 (1999) 110-119
24. Fischer U., Kopka L., and Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213 (1999) 881-888
25. Hata T., Takahashi H., Watanabe K., et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg 199 (2004) 173-174
26. Hlawatsch A., Teifke A., Schmidt M., et al. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol 179 (2002) 1493-1501
27. Hwang E.S., Kinkel K., Essermann L.J., et al. Magnetic resonance imaging in patients diagnosed with ductal carcinoma in situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 10 (2003) 381-388
28. Kneeshaw P.J., Turnbull L.W., Smith A., et al. Dynamic contrast enhanced magnetic resonance imaging aid: the surgical management of invasive lobular breast cancer. Eur Surg Oncol 29 (2003) 32-37
29. Kramer S., Schulz-Wendtland R., Hagedorn K., et al. Magnetic resonance imaging and its role in the diagnosis of multicentric breast cancer. Anticancer Res 18 (1998) 2163-2164
30. Liberman L., Morris E.A., Dershaw D.D., et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180 (2003) 901-910
31. Mumtaz H., Hall-Craigs M.A., Davidson T., et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169 (1997) 417-424
32. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Italian Trial for Breast MR in Multifocal/Multicentric Cancer. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breast using the whole breast pathologic examination as a gold standard. AJR Am J Roentgenol 183 (2004) 1149-1157
33. Schelfout K., Van Goethem M., Kersschot E., et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol 14 (2004) 1209-1216
34. Trecate G., Tess J.D., Vergnaghi D., et al. Lobular breast cancer: how useful is breast magnetic resonance imaging?. Tumori 87 (2001) 232-238
35. Van Goethem M., Schelfout, Dijckmans L., et al. MR Mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultraound. Eur Radiol 14 (2004) 809-816
36. Van Goethem M., Schelfout K., Kersschot E., et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol 62 (2007) 273-282
37. Winnekendonk G., Krug B., Warm M., et al. Diagnostischer Stellenwert der präoperativen MR-Mammographie (MRM). Fortschr Röntgenstr 176 (2004) 688-693
38. Boetes C., Strijk S.P., Holland R., et al. False negative MR imaging of malignant breast tumors. Eur Radiol 7 (1997) 1231-1234
39. Chung A., Saouaf R., Scharre K., et al. The impact of MRI on the treatment of DCIS. Am Surg 71 (2005) 705-710
40. Menell J.H., Morris E.A., Dershaw D.D., et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11 (2005) 382-390
41. Shiraishi A., Kurosaki Y., Maehara T., et al. Extension of ductal carcinoma in situ: histopathological association with MR imaging and mammography. Magn Reson Med Sci 2 (2003) 159-163
42. Viehweg P., Lampe D., Buchmann J., et al. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA 11 (2000) 129-137
43. Orel S.G., Mendonca M.H., Reynolds C., et al. MR imaging of ductal carcinoma in situ. Radiology 202 (1997) 413-420
44. Oshida K., Nagashima T., Ueda T., et al. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol 15 (2005) 1353-1360
45. Schouten van der Velden A.P., Boetes C., Bult P., et al. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 192 (2006) 172-189
46. Tamaki Y., Akashi-Tanaka S., Ishida T., et al. 3D imaging of intraductal spread of breast cancer and its clinical application for navigation surgery. Breast Cancer 9 (2002) 289-295
47. Do K.Y., Moon W.K., Cho N., et al. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol 8 (2007) 32-39
48. Neubauer H., Li M., Kuehne-Heid R., et al. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 76 (2003) 3-12
49. Holland R., Connolly J.L., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8 (1990) 113-118
50. Schnall M.D., Blume J., Bluemke D.A., et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 92 (2005) 32-38
51. Teifke A., Lehr H.A., Vomweg T.W., et al. Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. AJR Am J Roentgenol 181 (2003) 655-662
52. Lehman C.D., Gatsonis C., Kuhl C.K., et al., ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356 (2007) 1295-1303
53. Perlet C., Heywang-Kobrunner S.H., Heinig A., et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer 106 (2006) 982-990
54. Lampe D., Hefler L., Alberich T., et al. The clinical value of preoperative wire localization of breast lesions by magnetic resonance imaging: a multicenter study. Breast Cancer Res Treat 75 (2002) 175-179
55. Tan J.E., Orel S.G., Schnall M.D., et al. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol 22 (1999) 414-418
56. Tillman G.F., Orel S.G., Schnall M.D., et al. Effect of breast magnetic resonance imaging on the clinical management of women with early stage breat carcinoma. J Clin Oncol 20 (2002) 3413-3423
57. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14 (2004) 1725-1731
58. Wiener J.I., Schilling K.J., Adami C., et al. Assessment of suspected breast cancer by MRI: a prospective clinical trial using a combined kinetic and morphologic analysis. AJR Am J Roentgenol 184 (2005) 878-886
59. Zhang Y., Fukatsu H., Naganawa S., et al. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast Cancer 9 (2002) 231-239
60. Lee S.G., Orel S.G., Woo I.G., et al. MR imaging screening of the contralateral breast in patients with. newly diagnosed breast cancer. Radiology 226 (2003) 773-778
61. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 (2003) 333-341
62. Viehweg P., Rotter K., Laniado M., et al. MR-mammography of the contralateral breast in patients after breast conserving therapy. Eur Radiol 14 (2004) 402-408
63. Rieber A., Merkle E., Bohm W., et al. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 21 (1997) 773-777
64. Slanetz P.J., Edmister W.B., Yeh E.D., et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 8 (2002) 145-148
65. Diekmann F., Diekmann S., Beljavskaja M., et al. Preoperative MRI of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma. RoeFo 176 (2004) 544-549
66. Munot K., Dall B., Achuthan R., et al. Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br J Surg 89 (2002) 1296-1301
67. Quan M.L., Sclafani L., Heerdt A.S., et al. Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol 10 (2003) 1048-1053
68. Rodenko G.N., Harms S.E., Pruneda J.M., et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol 167 (1996) 1415-1419
69. Fredriksson I., Liljegren G., Palm-Sjovall M., et al. Risk factors for local recurrence after breast-conserving surgery. Br J Surg 90 (2003) 1093-1102
70. Morrow M., Strom E.A., Bassett L.W., et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 52 (2002) 277-300
71. Schwartz G.F., Veronesi U., Clough K.B., et al. Consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. Cancer 107 (2006) 242-250
72. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian. National Comprehensive Cancer Network (NCCN). V.I. (2007). http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf Available at: http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf
73. Liberman L., Mason G., Morris E.A., et al. Does size matter?. Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol 186 (2006) 426-430